威高血净
(603014)
| 流通市值：31.69亿 | | | 总市值：130.46亿 |
| 流通股本：1.01亿 | | | 总股本：4.18亿 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 1,758,243,796.68 | 904,266,262.9 | 3,768,719,939.38 | 2,736,052,670.24 |
| 营业收入 | 1,758,243,796.68 | 904,266,262.9 | 3,768,719,939.38 | 2,736,052,670.24 |
| 二、营业总成本 | 1,508,177,420.13 | 769,818,692.7 | 3,241,747,704.43 | 2,345,783,937.85 |
| 营业成本 | 1,092,272,570.71 | 552,327,288.04 | 2,252,667,429.83 | 1,622,620,708.78 |
| 税金及附加 | 27,868,185.5 | 11,337,981.54 | 52,632,207.36 | 38,627,463.44 |
| 销售费用 | 204,139,405.16 | 110,255,044.96 | 622,464,077.09 | 446,047,832.47 |
| 管理费用 | 109,456,803.4 | 54,510,842.8 | 167,331,096.28 | 132,273,878.93 |
| 研发费用 | 67,701,692.07 | 37,543,498.33 | 143,860,502.75 | 105,705,786.32 |
| 财务费用 | 6,738,763.29 | 3,844,037.03 | 2,792,391.12 | 508,267.91 |
| 其中:利息费用 | 523,335.88 | 369,556.34 | 743,115.28 | 283,020.98 |
| 其中:利息收入 | 2,409,330.29 | 245,917.99 | 2,135,383.1 | 1,593,221.93 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | 2,729,834.3 | 1,375,560.33 | 986,109.59 | 998,835.62 |
| 加:投资收益 | 26,995,205.64 | 15,220,850.02 | 31,028,152.2 | 33,720,777.75 |
| 资产处置收益 | 4,125.61 | -8,523.31 | 21,839.9 | 24,614.94 |
| 资产减值损失(新) | -10,914,062.69 | -8,914,537.56 | -5,699,923.67 | -7,772,260.54 |
| 信用减值损失(新) | -9,677,728.79 | -5,759,499.21 | 1,402,772.41 | -22,782,858.05 |
| 其他收益 | 7,441,812.5 | 4,332,750.04 | 27,272,791.28 | 17,076,905.61 |
| 四、营业利润 | 266,645,563.12 | 140,694,170.51 | 581,983,976.66 | 411,534,747.72 |
| 加:营业外收入 | 500,949.51 | 140,385.61 | 1,689,820.01 | 583,025.99 |
| 减:营业外支出 | 3,094,566.55 | 954,648.79 | 7,851,855.94 | 5,712,368.48 |
| 五、利润总额 | 264,051,946.08 | 139,879,907.33 | 575,821,940.73 | 406,405,405.23 |
| 减:所得税费用 | 34,335,228.25 | 21,577,233.62 | 93,510,930.42 | 65,627,345.88 |
| 六、净利润 | 229,716,717.83 | 118,302,673.71 | 482,311,010.31 | 340,778,059.35 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 229,716,717.83 | 118,302,673.71 | 482,311,010.31 | 340,778,059.35 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 229,758,624.3 | 118,304,254.26 | 482,296,672.53 | 340,778,059.35 |
| 少数股东损益 | -41,906.47 | -1,580.55 | 14,337.78 | - |
| 扣除非经常损益后的净利润 | 218,023,383.4 | 112,295,505.26 | 464,011,456.05 | 333,221,997.86 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.55 | 0.28 | 1.22 | 0.85 |
| (二)稀释每股收益 | 0.55 | 0.28 | 1.22 | 0.85 |
| 八、其他综合收益 | -167,259.22 | 245,179.79 | -134,366.87 | -59,253.35 |
| 归属于母公司股东的其他综合收益 | -167,259.22 | 245,179.79 | -134,366.87 | -59,253.35 |
| 九、综合收益总额 | 229,549,458.61 | 118,547,853.5 | 482,176,643.44 | 340,718,806 |
| 归属于母公司股东的综合收益总额 | 229,591,365.08 | 118,549,434.05 | 482,162,305.66 | 340,718,806 |
| 归属于少数股东的综合收益总额 | -41,906.47 | -1,580.55 | 14,337.78 | - |
| 公告日期 | 2026-08-26 | 2026-04-30 | 2026-03-28 | 2025-10-31 |
| 审计意见(境内) | | | 标准无保留意见 | |